GRB14 and glioblastoma: Knockdown of GRB14 (γ) or PDGFRα (δ) attenuated proliferation, radioresistance, apoptosis radioresistance, invasion, and migration abilities of glioblastoma cell lines previously treated with ldrEXOs (Figure 7A-E).